Improving HbA1c and Diabetes Preventative Screening Measures in Spanish-Speaking Patients With Clinical Pharmacist Care: A Quality Improvement Initiative

Purpose: To evaluate the impact of clinical pharmacist interventions on HbA1c and adherence to diabetes preventative screenings among Spanish-speaking adults with uncontrolled type 2 diabetes. Methods: This retrospective evaluation of a quality improvement initiative included Spanish-speaking adults with baseline HbA1c of 8% or greater who received at least 1 clinical pharmacist visit at a Federally Qualified Health Center. Outcomes included changes in glycemic control and timely preventive care screenings (diabetic eye exam, diabetic foot exam, urine albumin-to-creatinine ratio [UACR] test, and statin use), analyzed using logistical regression and McNemar’s test. Results: Among 70 included patients, the mean age was 55.6 years, with 65.7% of patients identifying as female and 62.9% having Medicaid insurance. The baseline mean HbA1c was 11.0%. Within 12 months, 40 patients achieved HbA1c